CompletedNCT01932398
A Study on the Inter-Hemispheric Alpha Ratio in Kids With ADHD (SHARK)
This study is completed. It focuses on ADHD and currently lists study information in the Netherlands.
In NijmegenADHDOtherFrom 84 Months to 95 Months
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT05137704
A Study on the Use of Healthcare Resources and Costs of Attention Deficit Hyperactivity Disorder (ADHD) in Adults in England
This study is completed in the United Kingdom. It focuses on ADHD.
In LondonADHDOtherOver 18 Years
CompletedNCT03666715
A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in adults with Schizophrenia in Portugal
This study is completed in Portugal. It focuses on schizophrenia.
In PortoSchizophreniaOtherFrom 18 Years to 55 Years
CompletedNCT05145413
KarXT for schizophrenia
This study is completed in the United States, in the United Kingdom, in Bulgaria, .... It is testing KarXT for schizophrenia.
Multiple locations, including PhoenixSchizophreniaOtherFrom 18 Years to 65 Years
CompletedNCT04659161
KarXT for schizophrenia
This study is completed in the United States. It is testing KarXT for schizophrenia.
Multiple locations, including Little RockSchizophreniaOtherFrom 18 Years to 65 Years
CompletedNCT04738123
KarXT for schizophrenia
This study is completed in the United States and in Ukraine. It is testing KarXT for schizophrenia.
Multiple locations, including BentonvilleSchizophreniaOtherFrom 18 Years to 65 Years
CompletedNCT02720263
Safety study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in schizophrenia
This study is completed in the United States. It is testing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 for schizophrenia.
In GlendaleSchizophreniaOtherFrom 18 Years to 60 Years
TerminatedNCT02216097
Effects Of PF-04457845 On BOLD fMRI In Subjects With PTSD
This study was terminated in the United States. It is testing Effects Of PF-04457845 On BOLD fMRI for PTSD.
In New YorkPTSDDrugA study involving a medication or substance.From 18 Years to 60 Years
TerminatedNCT03669640
Effects of RO6889450 (Ralmitaront) in people with Schizophrenia or Schizoaffective Disorder and Negative Symptoms
This study was terminated in the United States, in Japan, in Spain, .... It is testing Effects of RO6889450 (Ralmitaront) for schizophrenia.
Multiple locations, including BellflowerSchizophreniaOtherFrom 18 Years to 55 Years
CompletedNCT05919823
KarXT for schizophrenia
This study is completed in China. It is testing KarXT for schizophrenia.
Multiple locations, including HefeiSchizophreniaOtherFrom 18 Years to 65 Years
Active Not RecruitingNCT07038876
ML-007C-MA for schizophrenia
This study is active but not recruiting in the United States. It is testing ML-007C-MA for schizophrenia.
Multiple locations, including Little RockSchizophreniaOtherFrom 18 Years to 64 Years
CompletedNCT05972044
Solriamfetol for ADHD
This study is completed in the United States. It is testing solriamfetol for ADHD.
Multiple locations, including EncinoADHDOtherFrom 18 Years to 55 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.